DIVISLAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > divislab

Technical Analysis

Technical Strength: 8.1 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 64.1. According to RSI analysis, divislab is technically strong. 9.0 DIVISLAB RSI Chart
MACD (?) MACD: 26.2 and Signal Line: 24.0. According to MACD analysis, divislab is technically strong. 8.0 DIVISLAB MACD Chart
Simple Moving Average (?) According to simple moving average analysis, divislab is in a strong uptrend. Major support levels are 1782.253, 1734.596, 1659.508. 10.0 DIVISLAB Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, divislab is in a strong uptrend. Major support levels are 1783.835, 1739.858, 1632.821. 10.0 DIVISLAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.894. According to bollinger bands, divislab is technically strong. 7.0 DIVISLAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above all levels. Major support is at 1746.4291 and 1717.525. Resistance level is 1840.0. 6.5 DIVISLAB Fibonacci Retracement Chart
Average True Range (?) ATR: 37.5 NA DIVISLAB Average True Range Chart
Average Directional Index (?) ADX is 24.1 which means DIVISLAB is in a trading range and there is no trend. NA DIVISLAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
December 12, 2019
Open Price 1824.7
High Price 1840.0
Low Price 1813.1
Close Price 1829.15
Absolute Change 7.35
Percentage Change 0.403%
Weekly Change 1.53%
Monthly Change 10.4%
Yearly Change 25.6%
52-week high 1840.0
52-week low 1428.05
Corporate Actions
ExDate Purpose
August 14, 2019 AGM/DIV- RS 16 PER SH
August 31, 2018 AGM/DIV-RS 10 PER SHARE
September 15, 2017 AGM/DIV-RS 10/- PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.607
Confidence in Beta2.71%
Market Capital Rs. 48558.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 41.73
TTM Price-to-Earnings (P/E) Ratio 43.8
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 12 December 2019: Deliverable Quantity:1.45e+05 NA DIVISLAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 12 December 2019: Daily Volatility:0.2369 NA DIVISLAB Annualized Daily Volatility (Spot Price) Chart

Futures & Options Analysis

Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
PCR (?) 12 December 2019: PCR_OI:0.188 PCR:0.111 NA DIVISLAB PCR Chart
Option Pain (?) 12 December 2019: Max Pain:1800.0 NA DIVISLAB Option Pain Chart
Premium (?) 12 December 2019 Premium: 5.6 Futures OI:2272800.0 NA DIVISLAB Premium Chart
Option_MAX_OI (?) 12 December 2019: Price:1829.15 Put with maximum OI:1800.0 Call with maximum OI:1900.0 NA DIVISLAB Option_MAX_OI Chart

Futures - NSE

Expiry Date Close Price Open Interest Number of Trades No of Contracts Underlying Closing Price
December 26, 2019 1834.75 2272800.0 2347.0 2347.0 1829.15
January 30, 2020 1845.25 40400.0 36.0 36.0 1829.15
February 27, 2020 1844.05 6000.0 1.0 1.0 1829.15

Announcements

April 09, 2018 DrDisc. under Reg.30 of SEBI (SAST) Reg.2011r. Murali K. Divi has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
November 01, 2017 DiOutcome of Board Meetingivi's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on October 31, 2017.
See all Announcements

Board Meetings

Date Meeting Date Purpose
October 25, 2019 November 05, 2019 Financial Results To consider and approve the financial results for the period ended September 30, 2019
August 01, 2019 August 10, 2019 Financial Results To consider and approve the financial results for the period ended Jun 30, 2019
See all Board Meetings

DIVISLAB is part of...

Index Weightage
CNXPHARMA NA

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play